SCHAUMBURG, Ill., April 9, 2015 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB:WCUI) today announced the successful introduction of its targeted UV LED Phototherapy device, Psoria-Light®, at the recent 73rd Annual Meeting hosted by the American Academy of Dermatology in San Francisco, CA. Psoria-Light® is the first in the world DEEP UV LED Targeted Phototherapy device capable of effectively treating a variety of skin diseases such as Psoriasis, Eczema, and Vitiligo, without the risks and high costs associated with Excimer lasers. Psoria-Shield, Inc. (PSI) entered into several pre-purchase agreements with a number of US physicians at the show – with units expected to be delivered in late April to early May 2015.
Considered the premiere show serving the global dermatology community, the 73rd Annual Meeting hosted by the American Academy of Dermatology was a unique venue for introducing the Psoria-Light®. "Interest was extremely strong among physicians and medical distributors," according to John Yorke, Managing Director of The Medical Alliance (TMA). "Our initial research of the Psoria-Light® prior to our joint venture partnership with WCUI gave us compelling reasons to believe that we have a unique product capable of becoming the standard in the industry. However, having now dealt directly with the device and witnessing the level of interest from the dermatology sector, we have never felt more confident about the sales potential of the Psoria-Light® and our partnership with WCUI. I believe, hands-down, this is the best device on the market for treating certain skin diseases," Yorke added.
Psoria-Light's patented LED technology offers effective clinical and operational versatility in energy delivery which allows physicians to easily vary patient treatment parameters to accommodate each patient's needs. Psoria-Light's unique features enable service providers with extended benefits in patient outcomes, patient records, treatment comfort, and acquisition costs when compared to conventional Excimer lasers.
According to Chris Waugh, Founder and Director of The Medical Alliance, Psoria-Shield, Inc. anticipates having all primary US markets covered by August 2015. Waugh noted that "the International markets have long demonstrated interest in non-invasive phototherapy. With our regulatory certifications in place, we anticipate our sales launch to the European markets to begin later this year." Additionally, he added, "we are currently in negotiations with qualified and experienced distributors in India, Malaysia, and Australia to commence distribution of the Psoria-Light®. We anticipate these relationships to commence during this second quarter."
About Wellness Center USA, Inc.
Wellness Center USA, Inc. (www.wellnesscenterusa.com) is a hybrid healthcare company that combines best in class technologies, software, devices, providers, protocols, goods, and services. It was created to address important healthcare and wellness needs via breakthrough solutions, all centered around the "well-being of the body and mind". Wellness Center USA, Inc. is the parent company of three businesses reporting consolidated: Stealth Mark, National Pain Centers, and Psoria-Shield.
About The Medical Alliance, Inc.
The Medical Alliance (TMA) (http://themedalliance.com) represents the 2013 merger of The ComedIT Group, Ocean Medical, and TFGI; combining over 75 years experience in delivering integrated consulting services to manufacturers, distributors, and candidates in the medical device, supply, and information technology arenas. TMA has offices in Amsterdam, the Netherlands, Utica, NY, Coconut Grove, FL and Jacksonville, FL. TMA works with an array of specialty consultants and has close affiliations with over 120 specialty medical search firms.
Safe Harbor Statement:
Certain statements and projections contained in this presentation that are not statements or financial results of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements and projections include statements regarding any proposed exchange transactions, the anticipated closing date of such transactions and future results following a closing of the transactions. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "pending", "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transactions and plans which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transactions, difficulties in integrating operations following the transactions, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.
Source:Wellness Center USA, Inc.